MedCap AB Valuation
| MCAP Stock | SEK 543.00 26.00 4.57% |
At this time, the firm appears to be fairly valued. MedCap AB secures a last-minute Real Value of kr534.75 per share. The latest price of the firm is kr543.0. Our model forecasts the value of MedCap AB from analyzing the firm fundamentals such as Current Valuation of 3.15 B, return on equity of 0.15, and Profit Margin of 0.10 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that MedCap AB's price fluctuation is very steady at this time. Calculation of the real value of MedCap AB is based on 3 months time horizon. Increasing MedCap AB's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
MedCap AB's intrinsic value may or may not be the same as its current market price of 543.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 543.0 | Real 534.75 | Hype 543.0 |
The intrinsic value of MedCap AB's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence MedCap AB's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of MedCap AB helps investors to forecast how MedCap stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MedCap AB more accurately as focusing exclusively on MedCap AB's fundamentals will not take into account other important factors: MedCap AB Total Value Analysis
MedCap AB is now anticipated to have takeover price of 3.15 B with market capitalization of 3.57 B, debt of 165.4 M, and cash on hands of 139.7 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the MedCap AB fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.15 B | 3.57 B | 165.4 M | 139.7 M |
MedCap AB Investor Information
About 30.0% of the company outstanding shares are owned by corporate insiders. The book value of MedCap AB was now reported as 57.83. The company has Price/Earnings (P/E) ratio of 197.02. MedCap AB recorded earning per share (EPS) of 7.98. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 27th of September 2016. Based on the measurements of operating efficiency obtained from MedCap AB's historical financial statements, MedCap AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.MedCap AB Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. MedCap AB has an asset utilization ratio of 78.35 percent. This implies that the Company is making kr0.78 for each dollar of assets. An increasing asset utilization means that MedCap AB is more efficient with each dollar of assets it utilizes for everyday operations.MedCap AB Ownership Allocation
The market capitalization of MedCap AB is kr3.57 Billion. MedCap AB holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with substantial debt, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.MedCap AB Profitability Analysis
The company reported the revenue of 916.3 M. Net Income was 96.5 M with profit before overhead, payroll, taxes, and interest of 707.3 M.About MedCap AB Valuation
The stock valuation mechanism determines MedCap AB's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of MedCap AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of MedCap AB. We calculate exposure to MedCap AB's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of MedCap AB's related companies.MedCap AB is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. MedCap AB was founded in 2001 and is based in Stockholm, Sweden. MedCap AB operates under Medical Equipment classification in Sweden and is traded on Stockholm Stock Exchange.
8 Steps to conduct MedCap AB's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates MedCap AB's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct MedCap AB's valuation analysis, follow these 8 steps:- Gather financial information: Obtain MedCap AB's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine MedCap AB's revenue streams: Identify MedCap AB's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research MedCap AB's industry and market trends, including the size of the market, growth rate, and competition.
- Establish MedCap AB's growth potential: Evaluate MedCap AB's management, business model, and growth potential.
- Determine MedCap AB's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate MedCap AB's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for MedCap Stock Analysis
When running MedCap AB's price analysis, check to measure MedCap AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedCap AB is operating at the current time. Most of MedCap AB's value examination focuses on studying past and present price action to predict the probability of MedCap AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedCap AB's price. Additionally, you may evaluate how the addition of MedCap AB to your portfolios can decrease your overall portfolio volatility.